Incyte
INCY
#1180
Rank
โ‚น1.774 T
Marketcap
โ‚น8,916
Share price
1.73%
Change (1 day)
70.89%
Change (1 year)

Revenue for Incyte (INCY)

Revenue in 2025 (TTM): โ‚น450.79 Billion

According to Incyte's latest financial reports the company's current revenue (TTM ) is โ‚น477.81 Billion. an increase over the revenue in the year 2024 that were of โ‚น363.83 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Incyte from 1996 to 2025

Annual revenue

Year Revenue Change
2025 โ‚น461.52 B26.85%
2024 โ‚น363.83 B18.26%
2023 โ‚น307.65 B9.52%
2022 โ‚น280.90 B26.38%
2021 โ‚น222.27 B13.97%
2020 โ‚น195.02 B26.69%
2019 โ‚น153.94 B16.99%
2018 โ‚น131.58 B34.15%
2017 โ‚น98.08 B30.54%
2016 โ‚น75.13 B50.01%
2015 โ‚น50.09 B54.52%
2014 โ‚น32.41 B47.83%
2013 โ‚น21.92 B34.82%
2012 โ‚น16.26 B225.51%
2011 โ‚น4.99 B-34.36%
2010 โ‚น7.61 B1670.7%
2009 โ‚น0.42 B128.16%
2008 โ‚น0.18 B-86.06%
2007 โ‚น1.35 B10.39%
2006 โ‚น1.22 B246.73%
2005 โ‚น0.35 B-24.29%
2004 โ‚น0.46 B-78.25%
2003 โ‚น2.14 B-56%
2002 โ‚น4.87 B-53.94%
2001 โ‚น10.57 B16.75%
2000 โ‚น9.06 B32.74%
1999 โ‚น6.82 B19.11%
1998 โ‚น5.73 B63.5%
1997 โ‚น3.50 B137.26%
1996 โ‚น1.47 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚น5.267 T 1,002.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น5.815 T 1,117.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น6.057 T 1,167.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.415 T 614.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น24.91 B-94.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
โ‚น17.04 B-96.43%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚น7.04 B-98.53%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
โ‚น8.76 B-98.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚น37.01 B-92.25%๐Ÿ‡บ๐Ÿ‡ธ USA